<code id='C4857BA423'></code><style id='C4857BA423'></style>
      • <acronym id='C4857BA423'></acronym>
      <center id='C4857BA423'><center id='C4857BA423'><tfoot id='C4857BA423'></tfoot></center><abbr id='C4857BA423'><dir id='C4857BA423'><tfoot id='C4857BA423'></tfoot><noframes id='C4857BA423'>
      • <optgroup id='C4857BA423'><strike id='C4857BA423'><sup id='C4857BA423'></sup></strike><code id='C4857BA423'></code></optgroup>
        5. <b id='C4857BA423'><label id='C4857BA423'><select id='C4857BA423'><dt id='C4857BA423'><span id='C4857BA423'></span></dt></select></label></b><u id='C4857BA423'></u>
          <i id='C4857BA423'><strike id='C4857BA423'><tt id='C4857BA423'><pre id='C4857BA423'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / comprehensive / leisure time      
           
     
           
      
          leisure time 
           
      
           
      
           
       2025-09-28 04:40:10 
   
      
           
      
           
                        
          leisure time  
          
                                   
                 
                                      author：Wikipedia   
                                        
                                      
                                      Page View：3
                                  
                                    
          
                                   
          Franklin faces
          Adobe
          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.
          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.
          advertisement
          Arch declined to comment on the new fundraising.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Report captures long Covid’s disabling effects and policy challenges
                                
                            
          Next article：  
                                      
                                          Novavax promises a turnaround & Lilly roils the obesity market
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles